<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00804102</url>
  </required_header>
  <id_info>
    <org_study_id>EST-2008</org_study_id>
    <nct_id>NCT00804102</nct_id>
  </id_info>
  <brief_title>Transcorneal Electrical Stimulation Therapy for Retinal Disease</brief_title>
  <official_title>Transcorneal Electrical Stimulation Therapy for Retinal Disease - A Randomized, Single-blind Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Okuvision GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Okuvision GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transcorneal stimulation may enable neurons to survive degeneration processes via enhanced
      secretion of neurotrophic substances and direct stimulation of neurons.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>enhanced field of vision, enhanced visual acuity, lower threshold for electrical evoked phosphenes</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_arms>12</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Retinitis Pigmentosa</condition>
  <condition>Macula Off</condition>
  <condition>Primary Open Angle Glaucoma</condition>
  <condition>Hereditary Macular Degeneration</condition>
  <condition>Treated Retina Detachment</condition>
  <condition>Retinal Artery Occlusion</condition>
  <condition>Retinal Vein Occlusion</condition>
  <condition>Non-Arthritic-Anterior-Ischemic Optic-Neuropathy</condition>
  <condition>Hereditary Autosomal Dominant Optic Atrophy</condition>
  <condition>Dry Age Related Macular Degeneration</condition>
  <condition>Ischemic Macula Edema</condition>
  <arm_group>
    <arm_group_label>Retinitis pigmentosa</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Macula off</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>condition after treatment of retinal detachment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary open angle Glaucoma</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hereditary Macular Degeneration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Treated Retina detachment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Retinal Artery Occlusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Retinal Vein Occlusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Arteriitic-Anterior-Ischemic Optic-Neuropathy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hereditary autosomal dominant Optic atrophy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>dry Age-related Macular Degeneration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ischemic Macula edema</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-stimulated</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcorneal Electrical Stimulation</intervention_name>
    <description>Neurostimulator drives Dawson-Trick-Litzkow electrode attached to patient eye. Different modi are used to stimulate patients.</description>
    <arm_group_label>Retinitis pigmentosa</arm_group_label>
    <arm_group_label>Macula off</arm_group_label>
    <arm_group_label>Primary open angle Glaucoma</arm_group_label>
    <arm_group_label>Hereditary Macular Degeneration</arm_group_label>
    <arm_group_label>Treated Retina detachment</arm_group_label>
    <arm_group_label>Retinal Artery Occlusion</arm_group_label>
    <arm_group_label>Retinal Vein Occlusion</arm_group_label>
    <arm_group_label>Non-Arteriitic-Anterior-Ischemic Optic-Neuropathy</arm_group_label>
    <arm_group_label>Hereditary autosomal dominant Optic atrophy</arm_group_label>
    <arm_group_label>dry Age-related Macular Degeneration</arm_group_label>
    <arm_group_label>Ischemic Macula edema</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DTL-electrode attached without energy</intervention_name>
    <description>DTL-electrode attached to patient eye receives no energy from neurostimulator. Treatment times remain the same as used for each treatment arm.</description>
    <arm_group_label>Non-stimulated</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Retinitis pigmentosa, Macula off, Primary open angle Glaucoma, Hereditary Macular
             Degeneration, Treated Retina detachment, Retinal Artery Occlusion, Retinal Vein
             Occlusion, Non-Arthritic-Anterior-Ischemic Optic-Neuropathy, Hereditary autosomal
             dominant Optic atrophy, dry Age-related Macular Degeneration, Ischemic Macula edema

        Exclusion Criteria:

          -  Severe other disease such as non-proliferative diabetic retinopathy, exudative
             Age-related Macular Degeneration

          -  Age above 99 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florian Gekeler, MD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University-Eye-Hospital, Centre for Ophthalmology, D-72076 Tübingen, Germany</affiliation>
  </overall_official>
  <results_reference>
    <citation>Schatz A, Röck T, Naycheva L, Willmann G, Wilhelm B, Peters T, Bartz-Schmidt KU, Zrenner E, Messias A, Gekeler F. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study. Invest Ophthalmol Vis Sci. 2011 Jun 23;52(7):4485-96. doi: 10.1167/iovs.10-6932.</citation>
    <PMID>21467183</PMID>
  </results_reference>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2008</study_first_submitted>
  <study_first_submitted_qc>December 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2008</study_first_posted>
  <last_update_submitted>May 3, 2012</last_update_submitted>
  <last_update_submitted_qc>May 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Retinitis pigmentosa</keyword>
  <keyword>Macula off</keyword>
  <keyword>Primary open angle Glaucoma</keyword>
  <keyword>Hereditary Macular Degeneration</keyword>
  <keyword>Treated Retina detachment</keyword>
  <keyword>Retinal Artery Occlusion</keyword>
  <keyword>Retinal Vein Occlusion,</keyword>
  <keyword>Non-Arthritic-Anterior-Ischemic Optic-Neuropathy</keyword>
  <keyword>Hereditary autosomal dominant Optic atrophy</keyword>
  <keyword>dry Age-related Macular Degeneration</keyword>
  <keyword>Ischemic Macula edema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Retinal Vein Occlusion</mesh_term>
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
    <mesh_term>Cone-Rod Dystrophies</mesh_term>
    <mesh_term>Optic Nerve Diseases</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Optic Neuropathy, Ischemic</mesh_term>
    <mesh_term>Retinal Artery Occlusion</mesh_term>
    <mesh_term>Optic Atrophy</mesh_term>
    <mesh_term>Optic Atrophy, Autosomal Dominant</mesh_term>
    <mesh_term>Retinal Detachment</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>November 8, 2013</submitted>
    <returned>December 30, 2013</returned>
    <submitted>October 14, 2015</submitted>
    <returned>November 12, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

